Trinity Biotech (TRIB) Other financing activities (2023 - 2024)
Trinity Biotech recorded quarterly Other financing activities of $812.0 in Q1 2024, down 40.47% quarter-over-quarter from $1364.0 in Q1 2023, and down 40.47% year-over-year from $1364.0 in Q2 2023.
Trinity Biotech's Other financing activities history runs 2 years deep, the most recent figure standing at $812.0 for Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 812.00 |
| Mar 31, 2024 | 812.00 |
| Mar 31, 2023 | 1,364.00 |
| Mar 31, 2023 | 1,364.00 |